Dr. Reddy's Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%, the generic equivalent of Extra Strength Pataday Once-Daily Relief, in ...

The United States Patent and Trademark Office has issued U.S. Patent No. 12,514,854 B2, an Orange Book-listable patent ...

Dr. Reddy’s launched Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC), a generic equivalent of Extra-Strength Pataday® Once Daily Relief.

U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for ...

Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.

FAYETTEVILLE, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...

Mumbai: On Monday, January 12, at least 17 companies are scheduled to release their Q3 earnings for the December quarter of ...

A 33-year-old dispatch rider, Yahaya Nuru, was on Wednesday convicted and sentenced to a total of seven years’ imprisonment ...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...

Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengthsTwo differentiated treatments exemplify ...

In recent weeks, President Donald Trump and Colombian President Gustavo Petro have traded insults and threats that have ...

Authorities arrested two individuals and logged the evidence confiscated during a buy-bust operation at the Quezon Memorial ...